
Keywords: اینترفرون تقویت شده; Lymphatic; Biologic; Therapeutic proteins; Pharmacokinetics; Biodistribution; Intravenous; Trastuzumab; Interferon; Pegylated interferon; IFN-PEG40; 60 kDa Pegylated interferon α2a, PEGASYS®; IFN-PEG12;  ~ 31 kDa Pegylated interferon α2b, PEG-Intro